StockDuty ← Dashboard Aug 12, 2026 06:05 PM ET
CatalystFDA/Bio

Aprea Advances APR-1051; Phase 1 Enrollment Accelerates

APR-1051 Phase 1 enrollment acceleration signals key clinical catalyst for biotech investors.

What changed
Why it matters
APR-1051 Phase 1 enrollment acceleration signals key clinical catalyst for biotech investors.
Sources
eodhd
Related signals
PHASE 1 OF INDIA - US TRADE PACT HINGES ON SECTION 301 PROBE , OFFICIAL SAYS →PITNEY BOWES OUTLINES PHASE 2 STRATEGIC REVIEW WHILE PUSHING NEAREST DEBT MATURITY TO MARCH 2029 - SEEKINGALPHA →UNICYCIVE PLUMMETS FOLLOWING SECOND CRL FOR OLC FOR HYPERPHOSPHATEMIA - SEEKINGALPHA →